Glembatumumab Biosimilar (GPNMB Reference Antibody)
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity.
Product Specifications
Target
Glembatumumab Biosimilar (Anti-GPNMB Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
131714-FITC 100 µL
PPP2R2B (Serine/Threonine-protein Phosphatase 2A 55kD Regulatory Subunit B beta Isoform, PP2A, Subunit B Isoform B55-beta, PP2A Subunit B Isoform PR55-beta, PP2A Subunit B Isoform R2-beta, PP2A Subunit B Isoform beta, FLJ95686, MGC24888) (FITC)
Sign In for Pricing
View Details 
MBS1471880-01 0.02 mg (E-Coli)
Recombinant Rabbit fibroma virus Transcript termination protein A18 (s108R)
Sign In for Pricing
View Details MBS1471880-02 0.02 mg (Yeast)
Recombinant Rabbit fibroma virus Transcript termination protein A18 (s108R)
Sign In for Pricing
View Details MBS1471880-03 0.1 mg (E-Coli)
Recombinant Rabbit fibroma virus Transcript termination protein A18 (s108R)
Sign In for Pricing
View Details